関連文献

Urinary L-FABP: A Novel Biomarker for Evaluating Diabetic Nephropathy Onset and Progression. A Narrative Review.

Diabetes Ther. 2025. doi: 10.1007/s13300-025-01731-w.PubMed

Development of a multiple urinary biomarker model to predict the tubulointerstitial fibrosis area in patients with primary IgA Nephropathy.

BMC Nephrol. 2025. doi: 10.1186/s12882-025-04049-8.PubMed

Estimated Proximal Tubule Fluid Phosphate Concentration and Renal Tubular Damage Biomarkers in Early Stages of Chronic Kidney Disease.

J Ren Nutr. 2024.doi: 10.1053/j.jrn.2024.06.009.PubMed

Topiroxostat-A Safer Uricostatic Drug with Enhanced Renal Protection: A Narrative Review.

J Assoc Physicians India. 2024doi: 10.59556/japi.72.0724.PubMed

Diagnostic Accuracy of L-FABP-to-Creatinine Ratio (LCR) for Prediction of Kidney Damage in Type-2 DM Patients Taking Albumin-to-Creatinine Ratio (ACR) as Gold Standard.

J Pak Soc Intern Med. 2024.doi: jpsim.v5i4.2465JPSIM

Development of Liver Fibrosis Represented by the Fibrosis-4 Index Is a Specific Risk Factor for Tubular Injury in Individuals with Type 2 Diabetes.

Biomedicines. 2024doi: 10.3390/biomedicines12081789.PubMed

Estimated proximal tubule fluid phosphate concentration and renal tubular damage biomarkers in early stages of chronic kidney disease.

J Ren Nutr. 2024doi: 10.1053/j.jrn.2024.06.009.PubMed

Evaluation of Urinary L-FABP as a Tubular Damage Marker in Pediatric Neurogenic Bladder-A Pilot Study.

J Clin Med. 2024doi: 10.3390/jcm13030736.PubMed

Comparison of Urinary Liver Fatty Acid Binding Protein Level and Pathologic Biopsy Findings 1 Year After Kidney Transplantation.

Transplant Proc. 2024doi: 10.1016/j.transproceed.2023.12.016.PubMed

Urinary Liver-Type Fatty Acid Binding Protein, a Biomarker for Disease Progression, Dialysis and Overall Mortality in Chronic Kidney Disease.

J Pers Med. 2023doi: 10.3390/jpm13101481.PubMed